The first subject participated in cohort 1(low-dose group) of the Ib/IIa trial of allergic rhinitis immunotherapy, which is planned to recruit 16 subjects in this stage.

The first subject participated in cohort 1(low-dose group) of the Ib/IIa trial of allergic rhinitis immunotherapy, which is planned to recruit 16 subjects in this stage.

The first subject participated in cohort 1(low-dose group) of the Ib/IIa trial of allergic rhinitis immunotherapy, which is planned to recruit 16 subjects in this stage.

2019-03-26

Back

This site uses cookies to collect the necessary user browsing behavior so that we can provide you with a better browsing experience. Browse this site, which means you agree with "online privacy declaration."